發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  _____     _____     ______    _____     ______  
 /  ___||  |  ___||  /_____//  |  ___||  /_   _// 
| // __    | ||__    `____ `   | ||__    `-| |,-  
| \\_\ ||  | ||__    /___//    | ||__      | ||   
 \____//   |_____||  `__ `     |_____||    |_||   
  `---`    `-----`   /_//      `-----`     `-`'   
                     `-`